LEXICON PHARMACEUTICALS, INC. (LXRX) Total liabilities 2016–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) total liabilities at each fiscal year-end, per SEC filings.
$77.4MFY2025 · since FY2016: $318.2M → $77.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $77.4M | -49.2% |
| FY2024 | $152.5M | +11.8% |
| FY2023 | $136.3M | +76.6% |
| FY2022 | $77.2M | +231.0% |
| FY2021 | $23.3M | -50.8% |
| FY2020 | $47.4M | -84.2% |
| FY2019 | $300.6M | -3.2% |
| FY2018 | $310.5M | -15.7% |
| FY2017 | $368.3M | +15.7% |
| FY2016 | $318.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice